Penumbra Inc (NYSE: PEN) and Japan-based medical device manufacturer Asahi Intecc Co will collaborate to introduce Penumbra's Indigo Aspiration System into the Japanese market upon regulatory approval.
The Indigo Aspiration System can be used to remove emboli and thrombi from peripheral arterial and venous systems vessels and treat pulmonary embolism.
Indigo is a minimally-invasive device that enables blood flow restoration in cases such as acute limb ischemia and venous thrombus.
The newer generation device combines hypotube-based Indigo Aspiration Catheters with Lightning Intelligent Aspiration, a computer-aided clot detection technology that can differentiate between clot and blood, designed to reduce blood loss and the need for clot-dissolving drugs.
Penumbra's neurovascular thrombectomy and neurovascular and peripheral embolization devices will continue to be distributed by its long-time partner, Medico's Hirata.
Price Action: PEN shares are down 2.79% at $180.83 on the last check Thursday.
See more from Benzinga
Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.